Literature DB >> 33924961

The Holistic Coronary Physiology Display: Calculation of the Flow Separation Index in Vessel-Specific Individual Flow Range during Fractional Flow Reserve Measurement Using 3D Coronary Reconstruction.

Gábor Tamás Szabó1,2, Áron Üveges2,3, Balázs Tar2,3, András Ágoston2,3, Azzaya Dorj1, Csaba Jenei1,2, Rudolf Kolozsvári1,2, Benjamin Csippa4, Dániel Czuriga1,2, Zsolt Kőszegi1,2,3.   

Abstract

In order to make optimal decisions on the treatment of atherosclerotic coronary heart disease (CHD), appropriate evaluation is necessary, including both the anatomical and physiological assessment of the coronary arteries. According to current guidelines, a fractional flow reserve (FFR)-based clinical decision is recommended, but coronary flow reserve (CFR) measurements and microvascular evaluation should also be considered in special cases for a detailed exploration of the coronary disease state. We aimed to generate an extended physiological evaluation during routine FFR measurement and define a new pathological flow-related prognostic factor. Fluid dynamic equations were applied to calculate CFR on the basis of the three-dimensional (3D) reconstruction of the invasively acquired coronary angiogram and the measured intracoronary pressure data. A new, potentially robust prognostic parameter of a coronary lesion called the "flow separation index" (FSi), which is thought to detect the pathological flow amount through a stenosis was introduced in a vessel-specific flow range. Correlations between FSi and the clinically established physiological indices (CFR and FFR) were determined. The FSi was calculated in 19 vessels of 16 patients, including data from the pre- and post-stent revascularization treatment of 3 patients. There was no significant correlation between the FSi and the CFR (r = -0.23, p = 0.34); however, there was significant negative correlation between the FSi and the FFR (r = -0.66, p = 0.002). An even stronger correlation was found between the FSi and the ratio of the resting pressure ratio and the FFR (r = 0.92, p < 0.0001). The diagnostic power of the FSi for predicting the FFR value of <0.80, as a gold standard prognostic factor, was tested by receiver operating characteristic analysis. FSi > 0.022 proved to be the cutoff value of the prediction of a pathologically low FFR with a 0.856 area under the curve (95% confidence interval: 0.620 to 0.972). The present flow-pressure-velocity display provides a comprehensive summary of patient-specific pathophysiology in CHD. The consequences of epicardial stenoses can be evaluated together with their complex relations to microvascular conditions. Based on these values, clinical decision-making concerning both pharmacological therapy and percutaneous or surgical revascularization may be more precisely guided.

Entities:  

Keywords:  3D reconstruction; coronary flow reserve; fractional flow reserve

Year:  2021        PMID: 33924961     DOI: 10.3390/jcm10091910

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  35 in total

1.  A comparison of two methods to measure coronary flow reserve in the setting of coronary angioplasty: intracoronary blood flow velocity measurements with a Doppler catheter, and digital subtraction cineangiography.

Authors:  P W Serruys; F Zijlstra; G J Laarman; H H Reiber; K Beatt; J Roelandt
Journal:  Eur Heart J       Date:  1989-08       Impact factor: 29.983

Review 2.  Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.

Authors:  K Lance Gould; Nils P Johnson; Timothy M Bateman; Rob S Beanlands; Frank M Bengel; Robert Bober; Paolo G Camici; Manuel D Cerqueira; Benjamin J W Chow; Marcelo F Di Carli; Sharmila Dorbala; Henry Gewirtz; Robert J Gropler; Philipp A Kaufmann; Paul Knaapen; Juhani Knuuti; Michael E Merhige; K Peter Rentrop; Terrence D Ruddy; Heinrich R Schelbert; Thomas H Schindler; Markus Schwaiger; Stefano Sdringola; John Vitarello; Kim A Williams; Donald Gordon; Vasken Dilsizian; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

3.  Pressure-derived measurement of coronary flow reserve.

Authors:  Philip MacCarthy; Alexandre Berger; Ganesh Manoharan; Jozef Bartunek; Emanuele Barbato; William Wijns; Guy R Heyndrickx; Nico H J Pijls; Bernard De Bruyne
Journal:  J Am Coll Cardiol       Date:  2005-01-18       Impact factor: 24.094

4.  A.L. Copley Best Paper Prize 2019.

Authors:  Friedrich Jung; Philippe Connes; Christian Lehmann
Journal:  Clin Hemorheol Microcirc       Date:  2020-06-19       Impact factor: 2.375

5.  Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty.

Authors:  N H Pijls; J A van Son; R L Kirkeeide; B De Bruyne; K L Gould
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

6.  Assessment of coronary flow reserve by coronary pressure measurement: comparison with flow- or velocity-derived coronary flow reserve.

Authors:  Takashi Akasaka; Atsushi Yamamuro; Norio Kamiyama; Yuji Koyama; Maki Akiyama; Nozomi Watanabe; Yoji Neishi; Tsutomu Takagi; Evgeny Shalman; Chen Barak; Kiyoshi Yoshida
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

7.  Segmental comparison between coronary angiography and positron emission tomography reveals low predictive value of epicardial flow for viability.

Authors:  Z Koszegi; A Maes; J Piessens; F Van de Werf; L Mortelmans
Journal:  Eur Heart J       Date:  1998-06       Impact factor: 29.983

8.  Comparison of assessment of native coronary arteries by standard versus three-dimensional coronary angiography.

Authors:  Pierfrancesco Agostoni; Giuseppe Biondi-Zoccai; Glenn Van Langenhove; Kristoff Cornelis; Paul Vermeersch; Carl Convens; Corrado Vassanelli; Paul Van Den Heuvel; Frank Van Den Branden; Stefan Verheye
Journal:  Am J Cardiol       Date:  2008-05-22       Impact factor: 2.778

9.  Inducing Persistent Flow Disturbances Accelerates Atherogenesis and Promotes Thin Cap Fibroatheroma Development in D374Y-PCSK9 Hypercholesterolemic Minipigs.

Authors:  Ryan M Pedrigi; Christian Bo Poulsen; Vikram V Mehta; Niels Ramsing Holm; Nilesh Pareek; Anouk L Post; Ismail Dogu Kilic; Winston A S Banya; Gianni Dall'Ara; Alessio Mattesini; Martin M Bjørklund; Niels P Andersen; Anna K Grøndal; Enrico Petretto; Nicolas Foin; Justin E Davies; Carlo Di Mario; Jacob Fog Bentzon; Hans Erik Bøtker; Erling Falk; Rob Krams; Ranil de Silva
Journal:  Circulation       Date:  2015-07-15       Impact factor: 29.690

Review 10.  Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions.

Authors:  Li-Ming Gan; Johannes Wikström; Regina Fritsche-Danielson
Journal:  J Cardiovasc Transl Res       Date:  2013-07-23       Impact factor: 4.132

View more
  3 in total

1.  Pressure- and 3D-Derived Coronary Flow Reserve with Hydrostatic Pressure Correction: Comparison with Intracoronary Doppler Measurements.

Authors:  Balázs Tar; András Ágoston; Áron Üveges; Gábor Tamás Szabó; Tibor Szűk; András Komócsi; Dániel Czuriga; Benjamin Csippa; György Paál; Zsolt Kőszegi
Journal:  J Pers Med       Date:  2022-05-12

2.  Anatomical Assessment vs. Pullback REsting full-cycle rAtio (RFR) Measurement for Evaluation of Focal and Diffuse CoronarY Disease: Rationale and Design of the "READY Register".

Authors:  Zsolt Kőszegi; Balázs Berta; Gábor G Tóth; Balázs Tar; Áron Üveges; András Ágoston; Attila Szücs; Gábor Tamás Szabó; Judit Barta; Tibor Szük; Dániel Czuriga; András Komócsi; Zoltán Ruzsa
Journal:  Front Cardiovasc Med       Date:  2021-12-13

3.  Fractional Flow Reserve in the Diagnosis of Ischemic Heart Disease in a Patient with Coronary Artery Ectasia.

Authors:  Malgorzata Zalewska-Adamiec; Lukasz Kuzma; Hanna Bachorzewska-Gajewska; Slawomir Dobrzycki
Journal:  Diagnostics (Basel)       Date:  2021-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.